Tech Center 1600 • Art Units: 1613
This examiner grants 56% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18730898 | COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING INFLAMMATORY DISEASES COMPRISING EXTRACELLULAR VESICLES DERIVED FROM ROSEBURIA SPP. OR BIFIDOBACTERIUM SPP. | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18528620 | PERSONAL CARE SPRAY COMPOSITIONS AND METHODS COMPRISING TRANS-1-CHLORO-3,3,3-TRIFLUOROPROPENE | Final Rejection | HONEYWELL INTERNATIONAL INC. |
| 18034254 | OCULAR-TENSION-INCREASING AGENT CAPABLE OF BEING DEPRIVED OF DRUG ACTIVITY BY TEMPERATURE CONTROL | Non-Final OA | TOHOKU UNIVERSITY |
| 18543636 | COSMETIC EMULSION COMPRISING HYDROPHOBIC POLYMER | Non-Final OA | L'OREAL |
| 18544283 | MINERAL SUNSCREEN COMPOSITION COMPRISING HYDROPHOBIC POLYMER | Non-Final OA | L'OREAL |
| 18539466 | COSMETIC ADHESIVE COMPOSITIONS | Non-Final OA | L'OREAL |
| 18224119 | HAIR TREATMENT METHODS FOR SMOOTHING HAIR | Non-Final OA | L'OREAL |
| 18355516 | HAIR TREATMENT COMPOSITIONS AND METHODS FOR SMOOTHING HAIR | Non-Final OA | L'OREAL |
| 17787238 | METHOD FOR THE COSMETIC TREATMENT OF KERATIN FIBRES COMPRISING A STAGE OF APPLICATION OF A RARE EARTH METAL COMPOSITION AND A STAGE OF APPLICATION OF A COMPOSITION COMPRISING SURFACTANTS | Final Rejection | L'OREAL |
| 17779021 | COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS | Final Rejection | L'OREAL |
| 17563542 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | Final Rejection | CMPD Licensing, LLC |
| 18015575 | METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF | Non-Final OA | Generation Bio Co. |
| 18278774 | COSMETIC | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18487218 | INTERACTION BETWEEN ANTIMICROBIAL QUATERNARY COMPOUNDS AND ANIONIC SURFACTANTS | Non-Final OA | ECOLAB USA INC. |
| 18573452 | AQUEOUS MICROCAPSULE DISPERSION | Non-Final OA | KAO CORPORATION |
| 18281695 | COSMETIC COMPOSITION COMPRISING HINOKITIOL | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18723166 | 1H-PYRAZOLE-3-AMINE DERIVATIVE HAVING BICYCLIC BACKBONE | Non-Final OA | Sumitomo Pharma Co., Ltd. |
| 18570535 | ANTIBACTERIAL MATERIAL, ANTIBACTERIAL MATERIAL DISPERSION LIQUID, ANTIBACTERIAL MATERIAL DISPERSION BODY, AND METHOD FOR PRODUCING THEM | Non-Final OA | SUMITOMO METAL MINING CO., LTD. |
| 18648995 | ANTIHISTAMINES COMBINED WITH DIETARY SUPPLEMENTS FOR IMPROVED HEALTH | Final Rejection | REQUIS PHARMACEUTICALS INC. |
| 18264325 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Non-Final OA | Givaudan SA |
| 18690610 | EXOSOMES FROM COFFEE, GINKGO-BILOBA AND GINSENG | Non-Final OA | AYE EXOCURE TIBBI ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI |
| 17913747 | DMEU ENHANCER | Final Rejection | LTS LOHMANN THERAPIE-SYSTEME AG |
| 18434686 | MICROPARTICLES CONTAINING MOXIDECTIN, AND PREPARATION METHOD THEREFOR | Non-Final OA | INVENTAGE LAB INC. |
| 18548816 | DISSOCIATING POLYMER MATRIX COMPOSITIONS OF FULVESTRANT AND METHODS OF THEIR MAKING AND USE | Non-Final OA | VeraMorph LLC |
| 18354345 | COMPOSITIONS AND METHODS FOR FILTERING MICROORGANISMS FROM A FLUID | Non-Final OA | Food and Drug Administration |
| 18271169 | ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR | Non-Final OA | MOMENTIVE PERFORMANCE MATERIALS GMBH |
| 17840922 | POLYMERIC FATTY ACID SALT COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID-BASED SUBSTRATES, ESPECIALLY HAIR | Non-Final OA | Momentive Performance Materials GmbH |
| 18218274 | NANO BUBBLE-CONTAINING COSMETIC COMPOSITION | Final Rejection | H4 Co., Ltd. |
| 17632664 | PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE | Final Rejection | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
| 17828594 | SOLID DISPERSIONS | Final Rejection | DUPONT NUTRITION USA, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy